Table 1. Process and outcome measurements.
| Parameter | Process measure | Outcome measure |
|---|---|---|
| HbA1c | Percentage of patients measured | Mean HbA1c (mmol/mol) |
| Percentage HbA1c >53 mmol/mol | ||
| Diabetes treatment | Not applicable | Percentage diet only |
| Percentage oral medication only | ||
| Percentage insulin with or without oral medication | ||
| Systolic blood pressure | Percentage of patients measured | Mean SBP (mmHg) |
| Percentage SBP ≥140 mmHg | ||
| Hypertension treatment | Not applicable | Percentage patients using |
| antihypertensive drugs | ||
| Cholesterol-HDL ratio | Percentage of patients measured | Mean cholesterol-HDL ratio |
| Percentage cholesterol-HDL ratio ≥4 | ||
| Lipid lowering treatment | Not applicable | Percentage of patients using lipid lowering drugs |
| Renal function | Percentage of patients with ACR measurements | Percentage microalbuminuria: Women: ACR 3.5–35 mg/mmol; Men: ACR 2.5–25 mg/mmol |
| Percentage macroalbuminuria: Women: ACR >35 mg/mmol; Men: ACR >25 mg/mmol | ||
| Foot examination | Percentage of patient examined. (Tested 5.07 Semmes-Weinstein monofilaments). | Percentage of patients with diminished sensibility. (Defined as two or more errors in a test of three per foot). |
| Eye examination | Percentage of patients with retinascreening (investigated with a retinal camera). | Percentage of patients with DRP. |
| BMI | Percentage of patients measured | Mean BMI (kg/m2) |
| Percentage BMI ≥25 kg/m2 | ||
| Percentage BMI 25–30 kg/m2 | ||
| Percentage BMI ≥30 kg/m2 | ||
| Smoking | Percentage of patients asked | Percentage of smokers |
Abbreviations: SBP, systolic blood pressure; HDL, high-density lipoprotein; ACR, albumin-creatinine ratio; DRP, diabetic retinopathy; BMI, body mass index.